SCHEMBL29138599

SCHEMBL29138599

CC(C)(C)OC(=O)N1CC2(CC(c3ncc(Cl)cn3)C2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXTR P30559 1/20 0.48
AVPR1A P37288 1/20 0.48
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
NPSR1 Q6W5P4 2/20 0.41
USP2 O75604 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
GPR119 Q8TDV5 2/20 0.40
EIF2AK4 Q9P2K8 1/20 0.40
HSD11B1 P28845 2/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 1/20 0.39
NR1H2 P55055 1/20 0.39
EGLN2 Q96KS0 1/20 0.39
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP11B2 P19099 1/20 0.38
ACACB O00763 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30639343 0.88 GPR119 (0.46) MEN1KMT2ANPSR1USP2HPGD
SCHEMBL30639344 0.88 GPR119 (0.46) MEN1KMT2ANPSR1USP2HPGD
SCHEMBL3001224 0.83 HSD11B1 (0.47) MEN1KMT2ANPSR1USP2HPGD
SCHEMBL31572398 0.81 GPR119 (0.55) OXTRAVPR1AMEN1KMT2AGPR119
SCHEMBL31736852 0.81 GPR119 (0.57) MEN1KMT2ANPSR1USP2HPGD
SCHEMBL31622418 0.80 HSD11B1 (0.39) OXTRAVPR1AHSD11B1
SCHEMBL24838127 0.79 OXTR (0.43) OXTRAVPR1AGPR119POLBNR1H2
SCHEMBL29138624 0.79 NR1H2 (0.50) MEN1KMT2ANPSR1USP2HPGD
SCHEMBL29138582 0.79 HSD11B1 (0.61) MEN1KMT2ANPSR1USP2HPGD
SCHEMBL25327070 0.77 P2RX3 (0.48) OXTRAVPR1AGPR119EIF2AK4NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120157682-A Deuterated heterocyclic compounds as PDE4B inhibitors and uses thereof 武汉人福创新药物研发中心有限公司 2025-06-17 CN disclosed
WO-2023241684-A1 PDE4B INHIBITOR 武汉人福创新药物研发中心有限公司 2023-12-21 WO disclosed
WO-2023241683-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND ACTING AS PDE4B INHIBITOR 武汉人福创新药物研发中心有限公司 2023-12-21 WO disclosed
CN-117247395-A PDE4B inhibitors 武汉人福创新药物研发中心有限公司 2023-12-19 CN disclosed
CN-117247394-A Nitrogen-containing heterocycles as PDE4B inhibitors 武汉人福创新药物研发中心有限公司 2023-12-19 CN disclosed